EY refers to the global organization, and may refer to one or more, of the member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young Global Limited, a UK company limited by guarantee, does not provide services to clients.
Recent Searches
The health policy landscape continues to evolve, shaping strategies and operations across the healthcare industry and related sectors. Join us for a one-hour webcast that will provide a comprehensive update on key developments impacting the industry - helping your organization prepare for what’s ahead.
What you’ll learn from industry-dedicated EY professionals:
- FASB standards update: technical agenda highlights, including accounting for and disclosure of software costs and codification improvements
- 340B and IRA program developments: implications of the January 1, 2026, go live for the Inflation Reduction Act’s maximum fair price (MFP) provisions and the newly announced 340B rebate model
- Health policy priorities: what to expect from Congress and the administration heading into 2026
- Legislative and regulatory updates: implementation of the One Big Beautiful Bill Act, physician pay policy, drug pricing trends, tariffs and more
Presenters
- Laura Dillon, Senior Manager, Washington Council Ernst & Young, Ernst & Young LLP
- Julia Martin, Senior Manager, National Professional Practice Health and Not-for-Profit Industry Resident, Ernst & Young LLP
- Heather Meade, Principal, Washington Council Ernst & Young, Ernst & Young LLP
- Joan Palermo, EY Americas Health Leader – Audit Services
- Garrett Pape, Principal, Ernst & Young LLP
- Lindsey Roe, Partner, National Health Technical Leader, Ernst & Young LLP